This inventor holds 4 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2016-2017.
Company Filing History:
Years Active: 2016-2017
Title: Budde Mahendar: Innovator in Pharmaceutical Chemistry
Introduction
Budde Mahendar is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as potential therapeutic agents. With a total of 4 patents to his name, Mahendar's work focuses on innovative solutions for critical health issues.
Latest Patents
Mahendar's latest patents include a groundbreaking process for the preparation of indolizine-based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors. This invention provides compounds of general formula 1 that can be utilized as PDE3 inhibitory agents. These derivatives have promising applications in both human and veterinary medicine, particularly for the treatment and prevention of diseases such as heart failure, dilated cardiomyopathy, platelet inhibitors, cancer, and obstructive pulmonary diseases.
Another notable patent involves pyridopyrimidine-based derivatives, which also serve as potential PDE3 inhibitors. Similar to his previous work, this invention outlines a process for the preparation of these compounds, emphasizing their therapeutic potential in addressing various medical conditions.
Career Highlights
Budde Mahendar is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on creating effective therapeutic solutions.
Collaborations
Mahendar collaborates with esteemed colleagues, including Saidulu Mattapally and Mettu Ravinder, to further enhance the impact of his research. Their combined expertise contributes to the successful development of new pharmaceutical compounds.
Conclusion
Budde Mahendar's contributions to pharmaceutical chemistry exemplify the importance of innovation in addressing critical health challenges. His patents reflect a dedication to improving therapeutic options for various diseases, showcasing the potential of his research in the medical field.